查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864721

栓塞保护装置市场依产品类型、应用、最终用户和手术方式划分－2025年至2032年全球预测

Embolic Protection Devices Market by Product Type, Application, End User, Procedure - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，栓塞保护装置市场规模将达到 35.4 亿美元，复合年增长率为 8.36%。

关键市场统计数据
基准年 2024 18.6亿美元
预计年份：2025年 20.2亿美元
预测年份 2032 35.4亿美元
复合年增长率 (%) 8.36%

栓塞保护装置背景介绍：重点阐述临床重要性、技术进步以及装置实施过程中需要考虑的程序性因素

栓塞保护装置已成为现代血管内治疗中不可或缺的辅助手段，可降低远端栓塞风险，并在介入手术过程中保护脑部和周边微血管。其应用范围涵盖颈动脉置入术、经皮冠状动脉介入治疗和周边动脉介入治疗，装置的选择、术者技能和病例复杂程度均相互交织，共同影响临床结果。临床实务日益认识到，栓塞保护并非一成不变的解决方案；相反，装置的选择必须考虑病变位置、斑块形态、手术紧迫性和解剖结构限制。

器械设计、影像整合和手术流程的进步提高了人们对安全性和有效性的期望和标准。同时，治疗过程中的相关人员（介入医师、医院管理者和支付者）要求提供确凿的证据，证明其临床效益相对于手术复杂性和成本而言具有显着意义。因此，支持栓塞保护器材的生态系统目前正在努力平衡技术创新、临床检验和操作实用性。本引言阐述了支撑本执行摘要其余部分的临床背景和操作要务，为系统地探讨技术变革、监管影响、市场细分动态、区域差异、竞争行为以及行业相关人员可采取的策略奠定了基础。

器械工程、影像整合和手术环境的进步如何共同重新定义栓塞保护装置的研发和临床应用？

在临床需求趋于一致、材料科学进步以及手术模式不断演进的共同推动下，栓塞保护领域正经历多项变革性变化。滤网孔隙结构和阻塞机制的创新旨在最大限度地提高捕获效率，同时最大限度地减少血流中断，从而提升其与复杂解剖结构和迂曲血管的兼容性。此外，血管内超音波和高解析度血管造影术等先进影像技术的整合，使得器械定位更加精准，并能即时评估栓塞负荷，进而提高手术的准确性和疗效。

同时，手术流程的发展趋势正在影响器械的需求和设计选择。随着复杂的血管内手术从三级医疗机构扩展到门诊手术中心和专业导管室，简化器械操作流程、缩短手术时间以及确保不同经验水平的操作者都能获得可重复的结果变得日益重要。监管路径强调上市后监测和临床证据的生成，促使企业投资于註册研究和对比研究。这些变化正在加速产品系列的多样化，製造商们正在平衡一次性、可回收和基于闭塞的解决方案，以应对不同的临床场景。这些趋势正在塑造一个更精细、以功能主导的市场，该市场优先考虑临床可验证的价值和手术流程的整合。

评估近期美国关税如何影响医疗设备生态系统的供应链决策、製造地和商业协议。

展望2025年，美国关税政策格局正对医疗设备产业的製造商和供应商的全球供应链、筹资策略和生产区域化选择产生累积影响。关税压力已有效推高进口零件和成品的到岸成本，迫使原始设备製造商 (OEM) 和零件供应商重新评估其筹资策略。为此，一些企业正在加快近岸外包和回流生产，以降低关税波动风险并维持可预测的前置作业时间。虽然这种转型需要资本投资和营运重组，但从长远来看，有望降低供应链的复杂性。

关税带来的成本压力也将影响医院、门诊手术中心和导管室的合约签订行为。采购部门可能会考虑增加供应商多元化，并协商长期合约以稳定供应和价格。同时，製造商可能被迫在承担额外成本、调整标价或重新设计产品以使用来自不同供应商的替代组件之间做出选择。这些商业性决策与监管和报销方面的考虑并行，关税的影响可能会影响研发进度和打入市场策略。总体而言，关税环境正在推动采购、製造地和商业合约的策略调整，这些调整共同影响血栓栓塞保护装置相关人员如何管理成本和确保供应连续性。

透过对产品结构、临床应用、手术环境和最终用户环境进行详细的細項分析，揭示差异化的设备需求。

针对特定细分市场的洞察揭示了产品架构、临床应用、终端用户环境和手术环境如何导致不同的需求和商业化策略。根据产品类型，该领域可细分为多机制装置、基于滤网的解决方案和基于闭塞的系统。在基于滤网的技术中，永久性滤网和可回收滤网的设计在易用性和长期植入考虑因素之间呈现出不同的权衡；而闭塞方法则进一步细分为远端闭塞和近端闭塞策略，分别针对不同的解剖结构和栓塞风险特征。这些产品差异直接影响临床工作流程以及为获得医生认可所需的相应证据产生策略。

从临床角度来看，这些器械适用于颈动脉、冠状动脉和周边血管介入手术。颈动脉应用案例需要区分无症状和有症状的支架植入患者群体。冠状动脉植入必须考虑择期和急诊经皮冠状动脉介入治疗（PCI）的情况，在这些情况下，快速植入和最大限度减少血流中断至关重要。週边血管介入应用案例涵盖下肢介入到标靶肾动脉介入，血管大小和病变形态决定了器械的选择。终端使用者的回馈突显了门诊手术中心、心臟导管室和医院的运作实际情况，每个机构的采购流程、人员专业水平和手术吞吐量预期各不相同。最后，基于手术的细分（包括颈动脉置入术、经皮冠状动脉介入治疗和周边血管介入治疗）整合了上述各个方面，因为手术复杂性、患者风险状况和跨专业协作都会影响技术需求和临床结果预期。了解这些相互交织的细分层次，能够让相关人员将产品设计、临床证据和商业化策略与特定临床场景的精确需求相匹配。

区域趋势和医疗保健系统差异影响栓塞保护装置的临床应用、监管准入和供应链策略。

区域趋势影响着法规结构、报销模式、临床实践模式和供应链策略，从而为医疗器材的推广和商业化开闢了不同的路径。在美洲，高手术量、投资者对器械创新的浓厚兴趣以及对临床证据的高度重视，共同推动了先进防护技术的快速普及。同时，日益增长的合约压力和基于价值的采购方式也在影响采购决策。在欧洲、中东和非洲地区，监管的多样性和报销差异要求制定适应性强的市场进入策略。临床网路和区域註册库在证明器械在不同医疗基础设施环境下的有效性方面发挥着至关重要的作用。在亚太地区，基础设施的快速发展、介入治疗能力的不断提升以及政府主导的加强本地製造能力的倡议，正在改变着器械的上市和商业性规模化方式。

在全部区域，操作人员培训模式、医院采购週期以及公立和私立医疗保健比例的差异都会影响技术的推广应用速度。此外，供应链因素，例如零件采购限制、物流复杂性和区域监管时间表，也是本地化策略的真正驱动因素。因此，製造商和经销商必须调整全球产品开发，以利用跨境经验和效率，同时根据当地需求调整临床证据产生、定价策略和支援模式。这些区域差异凸显了灵活的商业化策略的重要性，这种策略既能适应当地的监管和临床实际情况，又不损害全球品质标准。

竞争格局概述：企业趋势着重于创新伙伴关係、证据生成以及差异化和规模化的策略方法。

栓塞保护装置领域的竞争格局由成熟的医疗设备製造商、规模较小的专业创新企业以及提供互补技术和组件的策略供应商组成。主要企业透过持续投资于工程、临床证据和扩充性来脱颖而出，并将产品改进与实践培训和支援计划相结合，以确保手术效果的一致性。同时，敏捷的创新者正在推出差异化材料、新型捕获机制和模组化系统设计，以满足特定的临床需求和尚未解决的外科难题。

伙伴关係和合作对于建立竞争优势至关重要。例如，与提供可靠临床数据的学术机构签订共同开发契约，以及与契约製造合作以优化成本结构并加快产品上市速度。併购是整合市场和快速取得能力的有效工具，使公司能够扩展产品组合或将稀缺的生产能力内部化。分销策略也不断多元化，有些公司优先考虑与医院建立直接关係，而有些公司则利用经销商网路来覆盖更广泛的终端用户。在这些策略中取得成功的公司能够平衡技术差异化和清晰的价值沟通，投资于上市后证据的收集，并保持灵活的供应链结构，以适应监管和商业环境的变化。

为医疗设备开发商和销售团队提供切实可行的策略行动，以加速产品推广，同时加强证据商业化和供应链韧性。

产业领导者应采取多管齐下的策略，整合临床证据、产品设计和商业性执行，以推动负责任的推广应用和长期永续性。首先，投资针对性强的临床项目，重点关注最有价值的适应症和手术环境，确保研究设计能够捕捉到有意义的终点指标，从而满足临床医生和支付方的利益。其次，优先考虑模组化产品开发，以便在不中断现有临床工作流程的情况下逐步升级产品功能，降低推广应用的门槛，并支援产品在临床上的广泛应用。

在营运层面，各机构应透过寻找替代供应商、评估近岸外包机会以及实施平衡库存和营运资金效率的库存管理政策来增强供应链韧性。商业策略应包括为医院、导管室和门诊手术中心製定客製化的市场推广策略，并实施强化培训项目，以减少手术流程的差异性并增强临床医生的信心。此外，各机构应透过儘早参与报销谈判以及将临床证据与编码和支付路径相匹配来降低采用门槛。最后，他们应与先进影像、数据分析和数位化培训平台等互补技术建立策略联盟，以提升手术价值并产生长期疗效数据。透过整合这些倡议，各机构可以改善患者预后、降低营运风险并打造强大的商业性差异化优势。

我们采用综合调查方法，结合临床医师访谈、文献综述、监管审查和供应链分析，以确保得出可靠的实证结论。

我们的研究途径结合了与临床和商业相关人员的定性对话，以及对已发表的临床文献、监管文件、临床试验註册资讯和医疗设备标籤的系统性回顾，以建立强有力的证据基础。主要研究内容包括与介入性心臟病专家、血管外科医师、导管室管理人员和采购负责人进行结构化访谈，以了解实际应用中的医疗设备使用模式、手术偏好和采购驱动因素。此外，我们还与监管专家和契约製造负责人进行了讨论，以了解生产限制和合规要求。

我们的二次研究整合了同行评审的临床研究、註册分析和公开监管文件的结果，以检验趋势并识别证据缺口。我们的数据综合强调跨资讯来源的三角验证，以反映临床实践经验和已记录的结果。我们也将供应链关键环节（例如，组件采购、物流路线和海关风险）的评估纳入调查方法，以便为我们的商业性建议提供更具体的背景资讯。最后，我们优先考虑资料来源的透明度以及我们对关键结论的信心，同时认识到真实世界证据的波动性和不断变化的监管指南所固有的局限性。

全面审视推动栓塞保护解决方案成功开发和部署的临床、技术和商业性要求。

总之，栓塞保护装置产业正经历一个实践创新期，其驱动力来自不断变化的临床需求、医疗机构间手术流程的转变以及材料和成像技术的进步。产品差异化如今取决于能否在最大限度减少手术干扰的情况下提供临床价值、拥有可靠的上市后证据以及灵活的供应链模式。关税趋势和区域监管差异进一步迫使企业优化筹资策略和商业化策略，以保持竞争力并确保供应的连续性。

展望未来，那些将临床洞察融入产品设计、投资于以结果为导向的证据生成，并开发灵活的商业性模式以应对医院、导管室和门诊手术中心实际运作情况的机构，将会取得成功。透过将卓越的技术与务实的市场推广和稳健的生产策略相结合，相关人员可以提高手术安全性，并扩大栓塞保护技术在各种医疗机构中的应用范围。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用新一代滤网技术，在颈动脉支架置放术中改善脑保护
  • 开发一种完全可回收的栓塞装置，以提高大隐静脉移植手术的安全性
  • 整合三维成像和感测器引导输送系统，以优化栓塞保护装置的放置。
  • 复杂週边血管手术中双滤器和闭塞球囊系统的应用日益增多
  • 透过增加对生物可吸收保护装置的投入，最大限度地减少长期血管併发症
  • 新兴市场扩张受医保报销政策改革和心血管疾病盛行率上升的推动
  • 透过医疗设备製造商和研究机构之间的合作，加速临床数据的生成

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的栓塞保护装置市场

  • 复合机制
  • 过滤器底座
    • 永久过滤器
    • 可回收过滤器
  • 闭塞基底
    • 远端咬合
    • 近端闭塞

9. 按应用分類的栓塞保护装置市场

  • 颈动脉
    • 无症状性支架置入术
    • 症状性支架置入术
  • 冠状动脉
    • 择期经皮冠状动脉介入治疗（PCI）
    • 紧急经皮冠状动脉介入治疗
  • 週边血管
    • 下肢干预
    • 肾臟血管介入治疗

10. 依最终用户分類的栓塞保护装置市场

  • 门诊手术中心
  • 心臟导管实验室
  • 医院

11. 依手术方式分類的栓塞保护装置市场

  • 颈动脉置入术
  • 经皮冠状动脉介入治疗
  • 週边动脉介入治疗

12. 按地区分類的栓塞保护装置市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

13. 依组别分類的栓塞保护装置市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国栓塞保护装置市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic plc
    • Cardinal Health, Inc.
    • Terumo Corporation
    • Nipro Corporation
    • Asahi Intecc Co., Ltd.
    • Merit Medical Systems, Inc.
    • Johnson & Johnson
    • WL Gore & Associates, Inc.
Product Code: MRR-8958E923A6B8

The Embolic Protection Devices Market is projected to grow by USD 3.54 billion at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.86 billion
Estimated Year [2025] USD 2.02 billion
Forecast Year [2032] USD 3.54 billion
CAGR (%) 8.36%

Contextual introduction to embolic protection devices highlighting clinical importance technological progress and procedural considerations shaping device adoption

Embolic protection devices have become integral adjuncts to contemporary endovascular therapies, reducing distal embolization risk and protecting cerebral and peripheral microvasculature during interventional procedures. Their role spans carotid artery stenting, percutaneous coronary interventions, and peripheral artery interventions, where device selection, operator technique, and case complexity converge to influence clinical outcomes. The clinical community increasingly recognizes that embolic protection is not a one-size-fits-all solution; rather, device choice must reflect lesion location, plaque morphology, procedural urgency, and anatomical constraints.

Advances in device design, imaging integration, and procedural workflows have elevated both expectations and standards for safety and efficacy. At the same time, stakeholders across the care continuum-interventionalists, hospital administrators, and payers-demand robust evidence demonstrating meaningful clinical benefit relative to procedural complexity and cost. Consequently, the ecosystem that supports embolic protection devices now balances engineering innovation with clinical validation and operational practicality. This introduction establishes the clinical context and operational imperatives that underpin the remainder of this executive summary, setting the stage for a structured review of technological shifts, regulatory impacts, segmentation dynamics, regional variations, competitive behavior, and actionable strategies for industry participants.

How advances in device engineering imaging integration and procedural settings are collectively redefining embolic protection device development and clinical use

Several transformative shifts are reshaping the embolic protection landscape, driven by converging clinical priorities, material science progress, and evolving procedural paradigms. Innovations in filter pore architecture and occlusion mechanics have focused on maximizing capture efficiency while minimizing flow disruption, making devices more compatible with complex anatomies and tortuous vasculature. Moreover, the integration of advanced imaging-such as intravascular ultrasound and high-resolution angiography-enables more precise device deployment and real-time assessment of embolic burden, thereby improving procedural confidence and outcomes.

Concurrently, procedural trends influence device demand and design choices. As complex endovascular interventions expand beyond tertiary centers into ambulatory surgical settings and specialized catheterization laboratories, there is increasing pressure to simplify device workflows, reduce procedural time, and ensure reproducible outcomes across operator experience levels. Regulatory pathways have emphasized post-market surveillance and clinical evidence generation, which in turn incentivize companies to invest in registries and comparative studies. These shifts are accelerating the diversification of product portfolios, with manufacturers balancing single-use, retrievable, and occlusion-based solutions to address distinct clinical scenarios. Taken together, these dynamics are creating a more nuanced and capability-driven market that prioritizes clinically demonstrable value and procedural integration.

Assessment of how recent United States tariff measures are reshaping supply chain decisions manufacturing footprints and commercial contracting across the device ecosystem

The 2025 tariff landscape in the United States is exerting a cumulative influence on global supply chains, procurement strategies, and production localization choices for manufacturers and suppliers in the medical device sector. Tariff pressures raise the effective landed cost of imported components and finished goods, prompting OEMs and component suppliers to reevaluate sourcing strategies. In response, some organizations are accelerating nearshoring or reshoring initiatives to mitigate exposure to tariff volatility and to maintain more predictable lead times. This transition requires capital investment and operational restructuring but can reduce complexity in the longer term.

Tariff-induced cost pressure also affects contracting behavior across hospitals, ambulatory surgical centers, and catheterization laboratories. Procurement teams may seek broader supplier diversification or negotiate longer-term agreements to stabilize supply and pricing. Manufacturers, in turn, face choices between absorbing incremental costs, adjusting list pricing, or redesigning products to use alternative components with different sourcing footprints. These commercial decisions occur alongside regulatory and reimbursement considerations, meaning that tariff effects can influence development timelines and market access strategies. Overall, the tariff environment is catalyzing strategic adjustments across sourcing, manufacturing footprint, and commercial contracting that collectively shape how embolic protection device stakeholders navigate cost and continuity of supply.

Deep segmentation analysis connecting product architecture clinical applications procedural contexts and end user environments to reveal differentiated device requirements

Segment-specific insights reveal how product architecture, clinical application, end user environment, and procedural context drive distinct needs and commercialization approaches. Based on product type, the space divides among combined mechanism devices, filter based solutions, and occlusion based systems; within filter based technologies, permanent and retrievable filter designs present different trade-offs between ease of use and long-term implant considerations, while occlusion approaches further bifurcate into distal and proximal occlusion strategies that address different anatomic and embolic risk profiles. These product distinctions directly influence clinical workflows and the associated evidence generation strategies required to achieve physician adoption.

When viewed through the lens of clinical application, devices are applied in carotid, coronary, and peripheral interventions; carotid use cases necessitate differentiation between asymptomatic stenting and symptomatic stenting populations, coronary deployment must account for elective PCI versus emergency PCI contexts where rapid deployment and minimal flow interruption are critical, and peripheral intervention use cases range from lower extremity interventions to targeted renal interventions where vessel size and lesion morphology dictate device selection. End user insights underscore operational realities across ambulatory surgical centers, cardiac catheterization laboratories, and hospitals, each setting presenting distinct procurement processes, staff expertise, and procedural throughput expectations. Finally, procedure-based segmentation-encompassing carotid artery stenting, percutaneous coronary intervention, and peripheral artery intervention-ties the preceding dimensions together, as procedural complexity, patient risk profile, and multidisciplinary coordination shape both technology requirements and clinical outcomes expectations. Understanding these intersecting segmentation layers enables stakeholders to align product design, clinical evidence, and commercialization strategies with the precise demands of specific clinical scenarios.

Regional dynamics and healthcare system differences that determine clinical adoption regulatory access and supply chain strategies for embolic protection devices

Regional dynamics influence regulatory frameworks, reimbursement paradigms, clinical practice patterns, and supply chain strategies, creating differentiated pathways for device adoption and commercialization. In the Americas, procedural volumes, investor interest in device innovation, and a strong emphasis on clinical evidence combine to support rapid introduction of advanced protection technologies, while contracting pressures and value-based procurement increasingly influence purchasing decisions. Moving to Europe, Middle East & Africa, regulatory heterogeneity and varying reimbursement systems require adaptive market access approaches; clinical networks and regional registries play a key role in demonstrating device effectiveness across diverse healthcare infrastructures. In the Asia-Pacific region, rapid infrastructural development, expanding interventional capacity, and government initiatives to enhance local manufacturing capability are changing how devices are brought to market and scaled commercially.

Across these geographies, differences in operator training models, hospital procurement cycles, and the relative balance between public and private healthcare delivery systems affect adoption cadence. Moreover, supply chain considerations-such as component sourcing constraints, logistical complexity, and regional regulatory timelines-create practical drivers for localization strategies. As a result, manufacturers and distributors must tailor clinical evidence generation, pricing approaches, and support models to regional needs while coordinating global product development to capture cross-border learning and efficiencies. This regional nuance underscores the importance of flexible commercialization playbooks that accommodate local regulatory and clinical realities without compromising global quality standards.

Competitive landscape overview emphasizing innovation partnerships evidence generation and strategic pathways companies use to differentiate and scale

Competitive dynamics in the embolic protection device landscape are shaped by a mix of established medical device manufacturers, smaller specialized innovators, and strategic suppliers that provide complementary technologies or components. Leading organizations differentiate through sustained investments in engineering, clinical evidence, and scalability; they pair product enhancements with pragmatic training and support programs to ensure consistent procedural outcomes. At the same time, agile innovators introduce differentiated materials, novel capture mechanisms, and modular system designs that target niche clinical needs or address unmet procedural challenges.

Partnerships and collaborations are central to competitive positioning, whether through co-development arrangements with academic centers that produce robust clinical data or through alliances with contract manufacturers to optimize cost structures and accelerate time-to-market. Mergers and acquisitions remain viable pathways for both market consolidation and rapid capability acquisition, enabling companies to expand portfolios or internalize scarce manufacturing competencies. Distribution strategies also vary, with some players prioritizing direct hospital relationships and others leveraging distributor networks to reach a broader set of end users. Across these approaches, the companies that succeed balance technical differentiation with clear value communication, invest in post-market evidence collection, and maintain flexible supply chain architectures that can respond to regulatory and commercial shifts.

Practical strategic actions for device developers and commercial teams to strengthen evidence commercialization and supply chain resilience while accelerating adoption

Industry leaders should adopt a multi-faceted strategy that aligns clinical evidence, product design, and commercial execution to accelerate responsible adoption and long-term sustainability. First, invest in targeted clinical programs that address the highest-value indications and procedural contexts, ensuring that study designs capture meaningful endpoints that resonate with clinicians and payers. Second, prioritize modular product development that allows incremental feature upgrades without disrupting existing clinical workflows, thereby reducing adoption friction and supporting broader clinical acceptance.

Operationally, strengthen supply chain resilience by identifying alternative suppliers, evaluating nearshoring opportunities, and implementing inventory policies that balance availability with working capital efficiency. Commercial tactics should include tailored go-to-market playbooks for hospitals, catheterization laboratories, and ambulatory surgical centers, with focused training programs that reduce procedural variability and support clinician confidence. Additionally, pursue reimbursement engagement early, aligning clinical evidence with coding and payment pathways to reduce barriers to uptake. Finally, establish strategic partnerships for complementary technologies such as advanced imaging, data analytics, and digital training platforms to enhance procedural value and generate longitudinal outcomes data. By integrating these actions, organizations can improve patient outcomes, reduce operational risk, and create defensible commercial differentiation.

Comprehensive research methodology integrating clinician interviews literature synthesis regulatory review and supply chain analysis to ensure robust evidence-based conclusions

The research approach combined qualitative engagement with clinical and commercial stakeholders and systematic review of publicly available clinical literature, regulatory filings, trial registries, and device labeling to construct a robust evidence foundation. Primary inputs included structured interviews with interventional cardiologists, vascular surgeons, catheterization laboratory managers, and procurement professionals to capture real-world device usage patterns, procedural preferences, and purchasing drivers. These interviews were complemented by consultations with regulatory experts and contract manufacturing representatives to understand manufacturing sensitivities and compliance imperatives.

Secondary research consolidated findings from peer-reviewed clinical studies, registry analyses, and public regulatory documentation to validate trends and identify gaps in evidence. Data synthesis emphasized triangulation across sources to ensure findings reflected both front-line clinical experience and documented outcomes. The methodology also incorporated an assessment of supply chain touchpoints, including component sourcing, logistic pathways, and tariff exposure, to contextualize commercial recommendations. Finally, the research recognized limitations inherent in real-world evidence variability and evolving regulatory guidance, and therefore prioritized transparency about data sources and the confidence assigned to key conclusions.

Concluding synthesis of the clinical technological and commercial imperatives that will guide successful development and adoption of embolic protection solutions

In conclusion, the field of embolic protection devices is experiencing a period of pragmatic innovation driven by evolving clinical needs, procedural migration across care settings, and material and imaging advances. Product differentiation now hinges on the ability to deliver clinical value with minimal procedural disruption, robust post-market evidence, and adaptable supply chain models. Tariff dynamics and regional regulatory diversity further compel companies to refine sourcing and commercialization strategies to maintain competitiveness and supply continuity.

Looking ahead, success will favor organizations that integrate clinical insight into product design, invest in outcome-focused evidence generation, and develop flexible commercial approaches that accommodate the operational realities of hospitals, catheterization laboratories, and ambulatory surgical centers. By combining technical excellence with pragmatic go-to-market execution and resilient manufacturing strategies, stakeholders can improve procedural safety and expand access to embolic protection technologies across diverse healthcare environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of next generation filter technology to improve cerebral protection during carotid stenting procedures
  • 5.2. Development of fully retrievable embolic devices for enhanced safety in saphenous vein graft interventions
  • 5.3. Integration of 3D imaging and sensor guided delivery systems to optimize embolic protection placement
  • 5.4. Growing preference for dual filter and occlusion balloon systems in complex peripheral vascular procedures
  • 5.5. Increasing investment in bioresorbable protection devices to minimize long term vessel complications
  • 5.6. Emerging market expansion driven by reimbursement policy reforms and rising cardiovascular disease prevalence
  • 5.7. Collaboration between device manufacturers and research institutions to accelerate clinical data generation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Embolic Protection Devices Market, by Product Type

  • 8.1. Combined Mechanism
  • 8.2. Filter Based
    • 8.2.1. Permanent Filter
    • 8.2.2. Retrievable Filter
  • 8.3. Occlusion Based
    • 8.3.1. Distal Occlusion
    • 8.3.2. Proximal Occlusion

9. Embolic Protection Devices Market, by Application

  • 9.1. Carotid
    • 9.1.1. Asymptomatic Stenting
    • 9.1.2. Symptomatic Stenting
  • 9.2. Coronary
    • 9.2.1. Elective Pci
    • 9.2.2. Emergency Pci
  • 9.3. Peripheral
    • 9.3.1. Lower Extremity Intervention
    • 9.3.2. Renal Intervention

10. Embolic Protection Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Laboratories
  • 10.3. Hospitals

11. Embolic Protection Devices Market, by Procedure

  • 11.1. Carotid Artery Stenting
  • 11.2. Percutaneous Coronary Intervention
  • 11.3. Peripheral Artery Intervention

12. Embolic Protection Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Embolic Protection Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Embolic Protection Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Medtronic plc
    • 15.3.4. Cardinal Health, Inc.
    • 15.3.5. Terumo Corporation
    • 15.3.6. Nipro Corporation
    • 15.3.7. Asahi Intecc Co., Ltd.
    • 15.3.8. Merit Medical Systems, Inc.
    • 15.3.9. Johnson & Johnson
    • 15.3.10. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COMBINED MECHANISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERMANENT FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RETRIEVABLE FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ASYMPTOMATIC STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SYMPTOMATIC STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY ELECTIVE PCI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY EMERGENCY PCI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY LOWER EXTREMITY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY RENAL INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL ARTERY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CAROTID, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY FILTER BASED, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY OCCLUSION BASED, 2025-2032 (